Clene Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8® Treatment At the American Academy of Neurology Late-Breaking Science Session

Stock Information for Orchestra BioMed Holdings Inc Com

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Orchestra BioMed Holdings Inc Com

Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream
Clene to Present at the Emerging Growth Conference
Clene to Present at the Jones Healthcare and Technology Innovation Conference
Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights
Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment
Clene to Present at the 37TH Annual Roth Conference
Clene Inc. Rob Etherington, CEO, and Morgan Brown, CFO, to Present at the Investor Summit Virtual on March 11
Clene and APST Enter Into an Agreement to Support FDA's Recommendation for Long-Term NfL Biomarker Analyses of CNM-Au8®'s Impact on NfL Reduction

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.